Zobrazeno 1 - 10 of 31 pro vyhledávání: '"Lauren Moran"'
1
Akademický článek
A new data driven method for summarising multiple cause of death data
Autor: Annette Dobson, Paul McElwee, Mohammad Reza Baneshi, James Eynstone-Hinkins, Lauren Moran, Michael Waller
Publikováno v: BMC Medical Research Methodology, Vol 23, Iss 1, Pp 1-12 (2023)
Abstract Background National mortality statistics are based on a single underlying cause of death. This practice does not adequately represent the impact of the range of conditions experienced in an ageing population in which multimorbidity is common
Externí odkaz: https://doaj.org/article/a21f5b5085bb493884e366f917ee9404
Zobrazit plný text záznamu
3
Akademický článek
Using Linked Whole-Of-Population Data to Estimate Education-Related Inequalities in Cause-Specific Mortality in Australia
Autor: Jennifer Welsh, Grace Joshy, Lauren Moran, Kay Soga, Hsei Di Law, Danielle Butler, Karen Bishop, Michelle Gourley, James Eynstone-Hinkins, Lynelle Moon, Anthony Blakely, Emily Banks, Rosemary J Korda
Publikováno v: International Journal of Population Data Science, Vol 5, Iss 5 (2020)
Introduction Official Australian estimates of socioeconomic inequalities in cause-specific mortality have been based on area-level socioeconomic measures. Using area-level measures is known to underestimate inequalities. Objectives and Approach Us
Externí odkaz: https://doaj.org/article/bc7c2239ca5c4a2bba00633ea4cfee04
Zobrazit plný text záznamu
4
Quantifying cause-related mortality in Australia, incorporating multiple causes: observed patterns, trends and practical considerations
Autor: Karen Bishop, Margarita Moreno-Betancur, Saliu Balogun, James Eynstone-Hinkins, Lauren Moran, Chalapati Rao, Emily Banks, Rosemary J Korda, Michelle Gourley, Grace Joshy
Publikováno v: International Journal of Epidemiology. 52:284-294
Background Mortality statistics using a single underlying cause of death (UC) are key health indicators. Rising multimorbidity and chronic disease mean that deaths increasingly involve multiple conditions. However, additional causes reported on death
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8c9b72dab207b11503925d17dcfa5ea7
https://doi.org/10.1093/ije/dyac167
Zobrazit plný text záznamu
5
Data from Ponatinib (AP24534), a Multitargeted Pan-FGFR Inhibitor with Activity in Multiple FGFR-Amplified or Mutated Cancer Models
Autor: Victor M. Rivera, Tim Clackson, Frank Wang, William C. Shakespeare, Narayana I. Narasimhan, Qurish K. Mohemmad, Scott Wardwell, Lauren Moran, Matthew J. Wong, Joseph M. Gozgit
Members of the fibroblast growth factor receptor family of kinases (FGFR1–4) are dysregulated in multiple cancers. Ponatinib (AP24534) is an oral multitargeted tyrosine kinase inhibitor being explored in a pivotal phase II trial in patients with ch
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0f39a803ac9fd251dac4bfc2513c8a34
https://doi.org/10.1158/1535-7163.c.6536118
Zobrazit plný text záznamu
6
Data from Antitumor Activity of Ridaforolimus and Potential Cell-Cycle Determinants of Sensitivity in Sarcoma and Endometrial Cancer Models
Autor: Victor M. Rivera, Tim Clackson, Frank Wang, David Clapham, Lauren Moran, Scott D. Wardwell, Michelle Cookson, David Miller, Rachel M. Squillace
Ridaforolimus is a nonprodrug rapamycin analogue that potently inhibits mTOR and has shown significant activity in patients with metastatic sarcoma and endometrial cancer, two diseases where high unmet need remains. Here, we evaluated the activity of
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::19b2a7bd378bf98a50c639945bcc5363
https://doi.org/10.1158/1535-7163.c.6535366
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje